McCormick buys Unilever's food business in deal that values it at nearly $45 billion

McCormick will acquire most of Unilever's foods business in a deal valuing the unit at nearly $45B; McCormick pays $15.7B cash and Unilever and its shareholders will own 65% of the combined company. The transaction expands McCormick into spreads and condiments and will add billions of dollars in annual sales to the spice maker, while Unilever divests to focus on faster-growing personal care following its ice cream spin-off. The deal is consistent with a broader Big Food trend toward divestitures—Bain reports ~50% of 2024 consumer-products M&A activity came from divestitures.

Analysis

A consolidation-driven scale shift in condiments/spreads will reprice winners that can extract procurement, packaging and route-to-market synergies; investors should model 150–350bps of gross-margin tailwind over 12–36 months from centralized buying and SKU rationalization rather than relying on volume recovery alone. Retailer dynamics are the hidden lever: a larger supplier gains slotting and promotion negotiating power, compressing retailer pay-to-play revenue but inviting pushback via private-label expansion — expect an elongated tug-of-war that shows up first in trade spend and second in gross margin.

Integration risk is the primary near-term P&L wildcard. Realizable synergies are likely backloaded and sensitive to plant footprint decisions, union exposure and cross-border tax structuring; failure to consolidate manufacturing without incurring disruption could flip apparent margin accretion into a 100–200bps shock to EBITDA in year one. Financing and equity mix for any large portfolio combination will determine dilution and credit metrics — track net leverage and covenant headroom across the coming 6–18 months as the clearest early-warning metrics.

Second-order supply-chain effects favor large ingredient processors and global co-packers: higher, predictable volumes allow them to push productivity and price on smaller peers, accelerating supplier consolidation over 1–3 years. Competitors with weaker distribution or underinvested refrigeration/packaging (regional brands, some private-label suppliers) face forced M&A or margin compression; expect a flurry of bolt-on deals and plant closures within 12–24 months as players defend scale economics.

For investors the key calibration is execution vs narrative. Near-term multiple expansion will be tied to clear, quantifiable cadence on synergy delivery, SG&A as a percent of sales, and working-capital normalization; absent those metrics, market sentiment can swing 20–30% in 3–6 months. Watch commodity hedging disclosures and retailer trade spend line items as the most actionable leading indicators of whether the strategic story translates into sustainably higher free cash flow.

Key Decisions for Investors

• Long MKC (or equivalent scale-focused condiment/spice leader) 6–12 months: buy shares or buy 9–12 month ATM calls sized for a 20–25% upside if 150–300bps margin improvement is realized; set stop-loss at -10% or hedge with 3–4 month OTM puts to cap drawdown to ~8–10%.
• Pair trade: Long MKC / Short KHC (or nearest large regional competitor) 6–12 months to express expected margin dispersion from scale and procurement leverage; target +15% relative outperformance, cap position size so max portfolio exposure is 3–5% and tighten if spread narrows <5% within 3 months.
• Buy ADM or BG (large ingredient processors) 9–18 months: take a modest long (3–5% portfolio) to capture higher, more stable volumes to co-packers; reward = steady EBITDA uplift as sales mix shifts, risk = cyclical commodity swings—use quarterly hedges or delta-neutral options to limit downside.
• Short/hedge Unilever (UL) for 6–12 months via 6–9 month puts or buy-write if equity issuance risk and integration dilution appear in guidance; targeted payoff if market penalizes near-term cash-flow volatility — maintain close stop if company publishes clear synergy cadence within two quarterly updates.